annual EBITDA:
-$21.90M+$26.85M(+55.08%)Summary
- As of today (September 16, 2025), CRMD annual EBITDA is -$21.90 million, with the most recent change of +$26.85 million (+55.08%) on December 31, 2024.
- During the last 3 years, CRMD annual EBITDA has risen by +$7.36 million (+25.16%).
- CRMD annual EBITDA is now -620.91% below its all-time high of -$3.04 million, reached on December 31, 2012.
Performance
CRMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$20.52M-$296.70K(-1.43%)Summary
- As of today (September 16, 2025), CRMD quarterly EBITDA is $20.52 million, with the most recent change of -$296.70 thousand (-1.43%) on June 1, 2025.
- Over the past year, CRMD quarterly EBITDA has increased by +$34.59 million (+245.86%).
- CRMD quarterly EBITDA is now -1.43% below its all-time high of $20.82 million, reached on March 1, 2025.
Performance
CRMD quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$52.25M+$34.59M(+195.78%)Summary
- As of today (September 16, 2025), CRMD TTM EBITDA is $52.25 million, with the most recent change of +$34.59 million (+195.78%) on June 1, 2025.
- Over the past year, CRMD TTM EBITDA has increased by +$106.59 million (+196.16%).
- CRMD TTM EBITDA is now at all-time high.
Performance
CRMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CRMD EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +55.1% | +245.9% | +196.2% |
3 y3 years | +25.2% | +351.3% | +265.9% |
5 y5 years | -4.6% | +330.1% | +310.6% |
CRMD EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +55.1% | -1.4% | +229.6% | at high | +196.2% |
5 y | 5-year | -4.6% | +55.1% | -1.4% | +229.6% | at high | +196.2% |
alltime | all time | -620.9% | +55.1% | -1.4% | +222.8% | at high | +196.2% |
CRMD EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $20.52M(-1.4%) | $52.25M(+195.8%) |
Mar 2025 | - | $20.82M(+53.0%) | $17.67M(-193.1%) |
Dec 2024 | -$21.90M(-55.1%) | $13.61M(-606.0%) | -$18.98M(-59.9%) |
Sep 2024 | - | -$2.69M(-80.9%) | -$47.32M(-12.9%) |
Jun 2024 | - | -$14.07M(-11.1%) | -$54.34M(+5.5%) |
Mar 2024 | - | -$15.83M(+7.5%) | -$51.52M(+11.4%) |
Dec 2023 | -$48.75M(+60.3%) | -$14.73M(+51.6%) | -$46.23M(+16.5%) |
Sep 2023 | - | -$9.71M(-13.7%) | -$39.68M(+7.9%) |
Jun 2023 | - | -$11.25M(+6.7%) | -$36.79M(+9.1%) |
Mar 2023 | - | -$10.54M(+28.9%) | -$33.71M(+11.7%) |
Dec 2022 | -$30.41M(+3.9%) | -$8.18M(+19.8%) | -$30.18M(+1.4%) |
Sep 2022 | - | -$6.82M(-16.4%) | -$29.76M(-5.5%) |
Jun 2022 | - | -$8.17M(+16.5%) | -$31.49M(+7.9%) |
Mar 2022 | - | -$7.01M(-9.7%) | -$29.19M(-0.7%) |
Dec 2021 | -$29.26M(+8.1%) | -$7.77M(-9.1%) | -$29.38M(+6.4%) |
Sep 2021 | - | -$8.55M(+45.6%) | -$27.62M(+7.7%) |
Jun 2021 | - | -$5.87M(-18.5%) | -$25.65M(-10.6%) |
Mar 2021 | - | -$7.20M(+20.0%) | -$28.70M(+6.2%) |
Dec 2020 | -$27.08M(+29.3%) | -$6.00M(-8.8%) | -$27.04M(+2.7%) |
Sep 2020 | - | -$6.58M(-26.2%) | -$26.32M(+6.1%) |
Jun 2020 | - | -$8.92M(+61.2%) | -$24.81M(+16.4%) |
Mar 2020 | - | -$5.53M(+4.8%) | -$21.32M(+3.3%) |
Dec 2019 | -$20.93M(-21.9%) | -$5.28M(+4.0%) | -$20.63M(+56.5%) |
Sep 2019 | - | -$5.08M(-6.5%) | -$13.19M(-28.1%) |
Jun 2019 | - | -$5.43M(+12.1%) | -$18.33M(-14.5%) |
Mar 2019 | - | -$4.85M(-323.7%) | -$21.44M(-19.9%) |
Dec 2018 | -$26.79M(-18.5%) | $2.17M(-121.2%) | -$26.75M(-31.8%) |
Sep 2018 | - | -$10.22M(+19.7%) | -$39.22M(+0.7%) |
Jun 2018 | - | -$8.54M(-16.0%) | -$38.94M(+9.6%) |
Mar 2018 | - | -$10.16M(-1.3%) | -$35.54M(+7.8%) |
Dec 2017 | -$32.89M | -$10.30M(+3.5%) | -$32.97M(+13.4%) |
Sep 2017 | - | -$9.94M(+93.6%) | -$29.06M(+2.9%) |
Jun 2017 | - | -$5.14M(-32.3%) | -$28.23M(+0.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2017 | - | -$7.59M(+18.7%) | -$27.98M(+14.2%) |
Dec 2016 | -$24.74M(+48.7%) | -$6.39M(-29.9%) | -$24.50M(+11.5%) |
Sep 2016 | - | -$9.12M(+86.7%) | -$21.97M(+25.3%) |
Jun 2016 | - | -$4.88M(+18.7%) | -$17.54M(+4.5%) |
Mar 2016 | - | -$4.11M(+6.5%) | -$16.78M(-7.6%) |
Dec 2015 | -$16.64M(+87.2%) | -$3.86M(-17.6%) | -$18.17M(+10.0%) |
Sep 2015 | - | -$4.68M(+13.5%) | -$16.51M(-2.0%) |
Jun 2015 | - | -$4.13M(-24.9%) | -$16.86M(+82.9%) |
Mar 2015 | - | -$5.49M(+148.6%) | -$9.22M(-54.9%) |
Dec 2014 | -$8.89M(+81.0%) | -$2.21M(-56.0%) | -$20.43M(-5.5%) |
Sep 2014 | - | -$5.02M(-243.1%) | -$21.63M(+15.1%) |
Jun 2014 | - | $3.51M(-121.0%) | -$18.79M(-20.3%) |
Mar 2014 | - | -$16.71M(+391.3%) | -$23.59M(+207.0%) |
Dec 2013 | -$4.91M(+61.6%) | -$3.40M(+55.5%) | -$7.68M(+60.9%) |
Sep 2013 | - | -$2.19M(+69.6%) | -$4.78M(+33.5%) |
Jun 2013 | - | -$1.29M(+59.9%) | -$3.58M(+23.4%) |
Mar 2013 | - | -$806.10K(+63.4%) | -$2.90M(-3.0%) |
Dec 2012 | -$3.04M(-58.0%) | -$493.20K(-50.1%) | -$2.99M(+14.7%) |
Sep 2012 | - | -$989.10K(+61.8%) | -$2.61M(-38.1%) |
Jun 2012 | - | -$611.20K(-31.9%) | -$4.22M(-30.6%) |
Mar 2012 | - | -$897.20K(+712.7%) | -$6.08M(-15.0%) |
Dec 2011 | -$7.23M(-11.1%) | -$110.40K(-95.7%) | -$7.15M(-22.2%) |
Sep 2011 | - | -$2.60M(+5.0%) | -$9.19M(+15.1%) |
Jun 2011 | - | -$2.47M(+25.5%) | -$7.99M(+19.5%) |
Mar 2011 | - | -$1.97M(-8.3%) | -$6.68M(-17.3%) |
Dec 2010 | -$8.14M(+38.1%) | -$2.15M(+54.7%) | -$8.08M(-18.4%) |
Sep 2010 | - | -$1.39M(+18.8%) | -$9.90M(+6.2%) |
Jun 2010 | - | -$1.17M(-65.3%) | -$9.32M(+6.1%) |
Mar 2010 | - | -$3.37M(-15.0%) | -$8.78M(+45.3%) |
Dec 2009 | -$5.89M(+56.1%) | -$3.97M(+388.9%) | -$6.04M(+190.9%) |
Sep 2009 | - | -$811.30K(+28.8%) | -$2.08M(+64.1%) |
Jun 2009 | - | -$630.10K(-0.9%) | -$1.27M(+99.1%) |
Mar 2009 | - | -$635.70K | -$635.70K |
Dec 2008 | -$3.77M | - | - |
FAQ
- What is CorMedix Inc. annual EBITDA?
- What is the all time high annual EBITDA for CorMedix Inc.?
- What is CorMedix Inc. annual EBITDA year-on-year change?
- What is CorMedix Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for CorMedix Inc.?
- What is CorMedix Inc. quarterly EBITDA year-on-year change?
- What is CorMedix Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for CorMedix Inc.?
- What is CorMedix Inc. TTM EBITDA year-on-year change?
What is CorMedix Inc. annual EBITDA?
The current annual EBITDA of CRMD is -$21.90M
What is the all time high annual EBITDA for CorMedix Inc.?
CorMedix Inc. all-time high annual EBITDA is -$3.04M
What is CorMedix Inc. annual EBITDA year-on-year change?
Over the past year, CRMD annual EBITDA has changed by +$26.85M (+55.08%)
What is CorMedix Inc. quarterly EBITDA?
The current quarterly EBITDA of CRMD is $20.52M
What is the all time high quarterly EBITDA for CorMedix Inc.?
CorMedix Inc. all-time high quarterly EBITDA is $20.82M
What is CorMedix Inc. quarterly EBITDA year-on-year change?
Over the past year, CRMD quarterly EBITDA has changed by +$34.59M (+245.86%)
What is CorMedix Inc. TTM EBITDA?
The current TTM EBITDA of CRMD is $52.25M
What is the all time high TTM EBITDA for CorMedix Inc.?
CorMedix Inc. all-time high TTM EBITDA is $52.25M
What is CorMedix Inc. TTM EBITDA year-on-year change?
Over the past year, CRMD TTM EBITDA has changed by +$106.59M (+196.16%)